Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies
GlyToucan Accession Number: G09614AM
| Peak | Intensity |
|---|---|
| 204.2 | 1414.0 |
| 305.1 | 760.0 |
| 323.1 | 4055.0 |
| 408.3 | 911.0 |
| 412.9 | 411.0 |
| 434.3 | 753.0 |
| 455.8 | 185.0 |
| 484.3 | 309.0 |
| 485.2 | 1957.0 |
| 485.4 | 1039.0 |
| 486.2 | 306.0 |
| 498.1 | 1145.0 |
| 502.7 | 907.0 |
| 503.2 | 2906.0 |
| 515.1 | 3864.0 |
| 515.7 | 815.0 |
| 528.1 | 1355.0 |
| 535.7 | 8949.0 |
| 536.3 | 2888.0 |
| 536.8 | 4048.0 |
| 546.3 | 173.0 |
| 551.6 | 725.0 |
| 575.2 | 3183.0 |
| 576.3 | 568.0 |
| 587.7 | 834.0 |
| 588.3 | 851.0 |
| 595.8 | 840.0 |
| 596.4 | 1387.0 |
| 605.2 | 439.0 |
| 612.2 | 1388.0 |
| 616.8 | 7867.0 |
| 617.2 | 8059.0 |
| 617.7 | 3539.0 |
| 618.3 | 2078.0 |
| 618.8 | 1714.0 |
| 629.3 | 2040.0 |
| 630.3 | 1020.0 |
| 647.3 | 2179.0 |
| 665.3 | 566.0 |
| 668.2 | 1773.0 |
| 678.3 | 1544.0 |
| 711.3 | 1133.0 |
| 792.0 | 611.0 |
| 833.1 | 723.0 |
| 869.4 | 2514.0 |
| 870.3 | 719.0 |
| 876.6 | 664.0 |
| 892.4 | 126.0 |
| 911.3 | 2522.0 |
| 912.5 | 1942.0 |
| 989.5 | 707.0 |
| 1008.5 | 1166.0 |
| 1012.3 | 1505.0 |
| 1031.3 | 3139.0 |
| 1031.5 | 4056.0 |
| 1032.3 | 2025.0 |
| 1032.5 | 1715.0 |
| 1033.3 | 455.0 |
| 1043.5 | 965.0 |
| 1072.2 | 1482.0 |
| 1072.5 | 577.0 |
| 1073.1 | 2384.0 |
| 1092.4 | 505.0 |
| 1115.5 | 783.0 |
| 1132.4 | 794.0 |
| 1174.6 | 2324.0 |
| 1175.5 | 169.0 |
| 1336.6 | 439.0 |